TCT-410 Assessing Suitability for Short-Term DAPT: Thromboresistance, Albumin Retention, and Endothelial Function in the Resolute Onyx Zotarolimus Versus BioFreedom Biolimus-Eluting Coronary Stent Systems
نویسندگان
چکیده
منابع مشابه
Resolute zotarolimus eluting stent for treatment of long coronary lesions.
Historically the treatment of long coronary lesions required overlapping stents, which has been associated with higher incidence of cardiovascular events. The current availability of long drug eluting stentsizes has enabled treatment of such lesions with one, or at least fewer stents e reducing cost and areas of stent overlap. However, longer lesion and stent length continues to be associated w...
متن کاملNobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
PURPOSE To compare the 1-year outcomes of a durable polymer Zotarolimus-eluting stent (ZES) versus a biodegradable polymer Biolimus-eluting stent (BES) in patients undergoing percutaneous coronary intervention. MATERIALS AND METHODS A total of 2083 patients from 2 different registries, 1125 treated with BES in NOBORI registry and 858 received ZES in CONSTANT registry were included in this stu...
متن کاملPerformance of the resolute zotarolimus-eluting stent in small vessels.
BACKGROUND Drug eluting stents for the treatment of small vessel coronary artery disease have traditionally yielded inferior clinical outcomes compared to the use of DES in large vessels. The benefit of the second-generation Resolute zotarolimus-eluting stent (R-ZES) in small vessels was examined. METHODS Two-year clinical outcomes from five combined R-ZES studies were compared between patien...
متن کاملZotarolimus - eluting versus sirolimus - eluting coronary stent implantation review
The safety and efficacy of coronary stents, utilized for treatment of ischemic heart disease, have been evaluated extensively. In comparison with bare-metal stents, first-generation drug-eluting stents more than halved the need for target lesion revascularization, but long-term safety has been questioned, as the first-generation drug-eluting stents seem to be associated with a small, but increa...
متن کاملClinical review of the Resolute® zotarolimus-eluting stent for the treatment of coronary artery disease
Drug-eluting stents (DES) offer reduced rates of clinical and angiographic restenosis compared with bare-metal stents in patients with symptomatic coronary artery disease. Despite availability of multiple different DES, concerns remain regarding relative efficacy and long-term safety. A DES that has optimal efficacy that extends to higher risk cases – specifically to maintain low restenosis rat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2019
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2019.08.500